Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on October 13, 2022.

From October 13, 2022 to December 31, 2022, the company has repurchased 12,839 shares, representing 0.11% for KRW 993.61 million. With this, the company has completed the repurchase of 12,839 shares, representing 0.11% for KRW 993.61 million under the buyback announced on October 13, 2022.